Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79376 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Telmisartan Related Compound B (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C33H30N4O2Color and Shape:White PowderMolecular weight:514.23688Doxapram Related Compound B (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one hydrochloride)
CAS:Lactams, nesoiFormula:C22H29CIN2O2Color and Shape:White Off-White PowderMolecular weight:492.12738Metoclopramide Related Compound A (4-Acetamido-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C16H24ClN3O3Color and Shape:Off-White PowderMolecular weight:341.15062Terazosin Related Compound B (1-(4-Hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H24N4O5Color and Shape:White PowderMolecular weight:388.17467Azithromycin N-Oxide
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C38H72N2O13Color and Shape:White Crystalline PowderMolecular weight:764.50344Fexofenadine Related Compound B (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H39NO4·HCl·H2OColor and Shape:White PowderMolecular weight:555.27515Cefaclor δ-3 Isomer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H14ClN3O4SColor and Shape:Off-White Tan PowderMolecular weight:367.03935Bendamustine Related Compound A (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H23N3O4HClColor and Shape:White SolidMolecular weight:357.83Abacavir Related Compound B ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C10H14ON4ClColor and Shape:Cream PowderMolecular weight:241.08561Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C14H10ClNOColor and Shape:Light Yellow PowderMolecular weight:243.04509Cilostazol Related Compound C (1-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C31H45N9O2Color and Shape:White PowderMolecular weight:575.36962Methimazole Related Compound A (2,2-Dimethoxy-N-methylethanamine)
CAS:Amino-alcohols, other than those containing more than oneFormula:C5H13NO2Color and Shape:Colorless Light Yellow LiquidMolecular weight:119.09463Decitabine Related Compounds B and C Mixture (4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one and 4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-a-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H18Cl2N4O6andC22H18Cl2N4O6Color and Shape:White PowderMolecular weight:504.06034Zileuton Related Compound A (N-(1-Benzo[b]thien-2-ylethyl) urea)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H12N2OSColor and Shape:White PowderMolecular weight:220.06703Chloroxylenol Related Compound A (2-chloro-3,5-dimethylphenol)
CAS:Derivatives containing only halogen substitutes and theFormula:C8H9ClOColor and Shape:White FlakesMolecular weight:156.03419Dehydrocarteolol Hydrochloride (5-[3-(tert-Butylamino)-2-hydroxypropoxy]quinolin-2(1H)-one hydrochloride)
CAS:<p>Lactams not elsewhere specified or included</p>Formula:C16H22N2O3·HClColor and Shape:White Crystalline PowderMolecular weight:290.16304Norfloxacin Related Compound H (7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C19H22FN3O5Color and Shape:Off-White PowderMolecular weight:391.15435Adapalene Related Compound B (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C29H30O3Color and Shape:PowderMolecular weight:426.21949Ticagrelor Related Compound B
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C23H28F2N6O4SColor and Shape:White Off-White Crystalline PowderMolecular weight:522.18608Methotrexate Related Compound C ((S)-2-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzamido) pentanedioic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C20H21N7O6Color and Shape:Dark Yellow Orange PowderMolecular weight:455.15533
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
